Oscar Health (NYSE:OSCR – Free Report) had its price objective raised by The Goldman Sachs Group from $16.00 to $21.00 in a research note published on Thursday morning, Benzinga reports. The brokerage currently has a neutral rating on the stock.
Other analysts have also issued research reports about the company. Wells Fargo & Company upped their price objective on Oscar Health from $12.00 to $20.00 and gave the company an overweight rating in a report on Thursday, February 15th. TheStreet upgraded shares of Oscar Health from a d rating to a c- rating in a research report on Wednesday, February 21st. Finally, Raymond James assumed coverage on shares of Oscar Health in a report on Friday, March 22nd. They issued an outperform rating and a $20.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of Moderate Buy and an average target price of $15.00.
Check Out Our Latest Stock Report on Oscar Health
Oscar Health Price Performance
Shares of OSCR opened at $21.64 on Thursday. The firm has a market capitalization of $4.97 billion, a price-to-earnings ratio of -54.10 and a beta of 1.66. The stock’s fifty day moving average is $15.72 and its 200-day moving average is $12.31. Oscar Health has a one year low of $4.72 and a one year high of $22.68. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.19 and a current ratio of 1.10.
Oscar Health (NYSE:OSCR – Get Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.34. Oscar Health had a negative net margin of 0.82% and a negative return on equity of 5.77%. The company had revenue of $2.14 billion during the quarter, compared to analyst estimates of $1.99 billion. During the same period in the prior year, the business posted ($0.18) EPS. The business’s revenue for the quarter was up 45.8% compared to the same quarter last year. Equities analysts anticipate that Oscar Health will post -0.04 EPS for the current year.
Institutional Trading of Oscar Health
A number of hedge funds have recently bought and sold shares of OSCR. Avalon Trust Co purchased a new position in shares of Oscar Health in the first quarter worth approximately $69,000. Prevail Innovative Wealth Advisors LLC purchased a new position in Oscar Health during the 4th quarter worth approximately $92,000. Precision Wealth Strategies LLC acquired a new stake in Oscar Health during the 3rd quarter valued at $60,000. SG Americas Securities LLC purchased a new stake in shares of Oscar Health in the third quarter valued at $62,000. Finally, Cornerstone Investment Partners LLC acquired a new stake in shares of Oscar Health in the first quarter worth $178,000. 75.70% of the stock is owned by hedge funds and other institutional investors.
Oscar Health Company Profile
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also
Receive News & Ratings for Oscar Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Oscar Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
